iSpecimen (ISPC) Return on Sales (2020 - 2025)
Historic Return on Sales for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to 26.55%.
- iSpecimen's Return on Sales fell 259100.0% to 26.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.66%, marking a year-over-year decrease of 27300.0%. This contributed to the annual value of 1.38% for FY2024, which is 2900.0% down from last year.
- According to the latest figures from Q3 2025, iSpecimen's Return on Sales is 26.55%, which was down 259100.0% from 2.55% recorded in Q2 2025.
- In the past 5 years, iSpecimen's Return on Sales registered a high of 0.48% during Q2 2021, and its lowest value of 26.55% during Q3 2025.
- Its 5-year average for Return on Sales is 2.56%, with a median of 0.95% in 2022.
- As far as peak fluctuations go, iSpecimen's Return on Sales surged by 13700bps in 2024, and later tumbled by -259100bps in 2025.
- Quarter analysis of 5 years shows iSpecimen's Return on Sales stood at 0.8% in 2021, then grew by 8bps to 0.73% in 2022, then tumbled by -51bps to 1.1% in 2023, then crashed by -270bps to 4.06% in 2024, then crashed by -553bps to 26.55% in 2025.
- Its last three reported values are 26.55% in Q3 2025, 2.55% for Q2 2025, and 1.55% during Q1 2025.